Atea Pharmaceuticals, Inc. Assets, Current
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-12
- 2026-06-30: Assets, Current $228.66M.
- 2026-03-31: Assets, Current $263.20M.
- 2025-12-31: Assets, Current $310.99M.
- 2025-09-30: Assets, Current $336.14M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $228.66M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $263.20M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $310.99M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $336.14M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $385.60M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $433.71M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $462.36M 10-K · filed 2026-03-05 |
| 2024-09-30 | $486.91M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $506.37M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $548.76M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $590.46M 10-K · filed 2025-03-06 |
| 2023-09-30 | $603.32M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $620.83M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $632.39M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $660.92M 10-K · filed 2024-02-28 |
| 2022-09-30 | $681.93M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $689.45M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $713.23M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $772.40M 10-K · filed 2023-02-28 |
| 2021-09-30 | $842.95M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $871.11M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $840.14M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $863.48M 10-K · filed 2022-02-28 |
| 2020-09-30 | $108.41M 10-Q · filed 2020-12-10 |
| 2019-12-31 | $21.91M 10-K · filed 2021-03-30 |